Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 272 of the 275 references it cites were found in a registry or an index; 102 of the 220 sources its claims cite were checked for support.

Transition from inflammation to proliferation: a critical step during wound healing

Open access
Landén, Ning Xu, Li, Dongqing, Ståhle, Mona · 2016 · Cellular and Molecular Life Sciences

Abstract

The ability to rapidly restore the integrity of a broken skin barrier is critical and is the ultimate goal of therapies for hard-to-heal-ulcers. Unfortunately effective treatments to enhance healing and reduce scarring are still lacking. A deeper understanding of the physiology of normal repair and of the pathology of delayed healing is a prerequisite for the development of more effective therapeutic interventions. Transition from the inflammatory to the proliferative phase is a key step during healing and accumulating evidence associates a compromised transition with wound healing disorders. Thus, targeting factors that impact this phase transition may offer a rationale for therapeutic development. This review summarizes mechanisms regulating the inflammation-proliferation transition at cellular and molecular levels. We propose that identification of such mechanisms will reveal promising targets for development of more effective therapies.

Overview

CoChat Summary

TL;DR

This review argues that the transition from inflammation to proliferation is a critical, therapeutically targetable step in skin wound healing, and that failed or inefficient transition underlies chronic wounds and excessive scarring. It synthesizes cellular, molecular, transcriptional, epigenetic, and miRNA regulators—especially macrophages, bioactive lipids, redox signals, TLR negative feedback, transcription factors, and miRNAs—as candidate targets.

Key findings

  • Normal healing is described as four overlapping phases: haemostasis (0–several hours), inflammation (1–3 days), proliferation (4–21 days), and remodelling (21 days–1 year); inflammation usually lasts 2–5 days, neutrophils remain 2–5 days, monocytes are recruited approximately 3 days after injury, and wound-edge keratinocytes begin proliferating approximately 2–3 days after injury.
  • The macrophage M1-to-M2 phenotype switch is critical for resolving inflammation and tipping the balance to tissue repair; efferocytosis of neutrophils is a central element inducing this switch, and defective M1–M2 transition is implicated in chronic wounds, including iron overload and diabetes-related impairment.
  • Multiple regulators facilitate the inflammation–proliferation transition: bioactive lipid mediators (e.g., PGE2, lipoxins, resolvins, protectins, endocannabinoids, sphingolipids), redox signals (low ROS promote proliferation/angiogenesis; excessive ROS cause oxidative stress in chronic wounds), negative regulation of TLR signalling, transcription factors (GRs, ARs, ERs, PPARs, AP-1, E2F1, Smads, EGR1, Hox genes), epigenetic regulators, and miRNAs.
  • Chronic wounds and scarring are associated with excessive or prolonged inflammation; up to one-third of treated chronic wound patients experience four or more recurrence episodes, healed skin reaches maximum ∼80% of original tensile strength, and mouse studies have implicated more than 100 genes in skin wound healing.

Methods

  • Design: narrative review of mechanisms regulating the inflammation–proliferation transition in normal physiologic and impaired skin wound healing.
  • Data or sample: literature synthesis; no primary experimental sample, with evidence drawn from human studies and animal/ex vivo models including mouse, pig, rabbit, porcine burn, and Drosophila/zebrafish.
  • Main analysis: qualitative synthesis organized by cell types (e.g., macrophages, stromal cells), molecular pathways (bioactive lipids, redox, TLR signalling), transcription factors, epigenetic mechanisms, miRNAs, wound complications, and animal models.

Limitations

  • Stated: for most factors discussed, their expression pattern and function in abnormal wound healing remain unknown, and investigation across wounds of different aetiologies is needed for personalized wound treatment.
  • Stated: knowledge of adaptive immunity in wound healing is sparse; the exact role of epigenetic regulation in wound healing remains largely unexplored; the specific role of endocannabinoids in skin wound healing remains largely unexplored; and TLR expression/function in chronic wounds remains largely unknown.
  • Evident: as a narrative review, it does not report a systematic search, quality appraisal, or meta-analysis; animal models differ from human skin (e.g., mouse wound contraction versus human re-epithelialization, and greater hair density in mouse skin), limiting translation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00018-016-2268-0

Cites

272 of 272 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Negative regulators of Toll-like receptor signaling. TLR2, TLR4, TLR5, TLR9 activate myeloid differentiation primary-response protein 88 (MyD88)-dependent pathway. MYD88-adaptor-like protein (Mal) recruits MyD88 to TLR2 and TLR4. TLR3 activates TIR-domain-containing adapter-inducing interferon-β (TRIF)-dependent pathway. In association with TRIF-related adaptor molecule (TRAM), TLR4 can also activate TRIF-dependent pathway. Upon stimulation, MyD88 recruits IL-1 receptor-associated kinase (IRAK), which is activated by phosphorylation and then associates with TNF receptor-associated factor 6 (TRAF6), leading to the activation of transforming growth factor β-activated kinase (TAK1). TAK1 further activates the transcription factors NF-κB and AP-1 through MAPK and NF-κB pathways, respectively. TRIF binds to receptor-interacting protein 1 (RIP1) and TRAF6, also leading to the activation of NF-κB and MAPKs. TRIF also activates interferon regulatory factor 3 (IRF3) through TNFR-associated factor 3 (TRAF3). A plethora of inhibitory mechanisms have been identified in TLR signaling: (i) interference of ligand binding, e.g., soluble forms of TLR2 and TLR4 compete with membrane-bond forms of TLRs for ligands binding; (ii) reduction of TLR expression, e.g., TGF-β suppresses the expression and function of TLR4; (iii) degradation of TLRs, e.g., TRIAD3A binds to the cytoplasmic domain of TLR4 and TLR9 and promotes their ubiquitylation and degradation; (iv) inhibition of TLR downstream signaling, e.g., SOCS1, IRAKM, TOLLIP, IRAK2c/d, A20 and DUSP1; (v) change of structures of target genes through chromatin remodeling and histone modification, e.g., H2AK119 ubiquitylation and H3K27 trimethylation inhibit the expression of TLR-signal-targeted genes; (vi) microRNAs can regulate TLR signaling by targeting TLRs, downstream signaling proteins, related regulatory molecules, transcription factors as well as genes induced by TLR signaling. The figure was made with tools from www.proteinlounge.com
Fig. 1 Negative regulators of Toll-like receptor signaling. TLR2, TLR4, TLR5, TLR9 activate myeloid differentiation primary-response protein 88 (MyD88)-dependent pathway. MYD88-adaptor-like protein (Mal) recruits MyD88 to TLR2 and TLR4. TLR3 activates TIR-domain-containing adapter-inducing interferon-β (TRIF)-dependent pathway. In association with TRIF-related adaptor molecule (TRAM), TLR4 can also activate TRIF-dependent pathway. Upon stimulation, MyD88 recruits IL-1 receptor-associated kinase (IRAK), which is activated by phosphorylation and then associates with TNF receptor-associated factor 6 (TRAF6), leading to the activation of transforming growth factor β-activated kinase (TAK1). TAK1 further activates the transcription factors NF-κB and AP-1 through MAPK and NF-κB pathways, respectively. TRIF binds to receptor-interacting protein 1 (RIP1) and TRAF6, also leading to the activation of NF-κB and MAPKs. TRIF also activates interferon regulatory factor 3 (IRF3) through TNFR-associated factor 3 (TRAF3). A plethora of inhibitory mechanisms have been identified in TLR signaling: (i) interference of ligand binding, e.g., soluble forms of TLR2 and TLR4 compete with membrane-bond forms of TLRs for ligands binding; (ii) reduction of TLR expression, e.g., TGF-β suppresses the expression and function of TLR4; (iii) degradation of TLRs, e.g., TRIAD3A binds to the cytoplasmic domain of TLR4 and TLR9 and promotes their ubiquitylation and degradation; (iv) inhibition of TLR downstream signaling, e.g., SOCS1, IRAKM, TOLLIP, IRAK2c/d, A20 and DUSP1; (v) change of structures of target genes through chromatin remodeling and histone modification, e.g., H2AK119 ubiquitylation and H3K27 trimethylation inhibit the expression of TLR-signal-targeted genes; (vi) microRNAs can regulate TLR signaling by targeting TLRs, downstream signaling proteins, related regulatory molecules, transcription factors as well as genes induced by TLR signaling. The figure was made with tools from www.proteinlounge.comCC BY · PubMed Central
Fig. 2 The roles of macrophage in wound healing. In the early phase of wound repair, upon exposure to pro-inflammatory cytokines, interferons (IFNs), PAMPs or DAMPs, infiltrating monocytes and resident macrophages are activated and mainly acquire a pro-inflammatory M1 phenotype. They perform phagocytosis of microbes, scavenge cellular debris and produce pro-inflammatory mediators. Later during healing process, IL4, IL-10, Glucocorticoids, Prostaglandins (PGs) and modulators of glucose and lipid metabolism induce macrophages to transit to a reparative M2 phenotype, which secret anti-inflammatory mediators and growth factors. Macrophages also remove neutrophils in the wounds by phagocytosis, a central element to induce the M1-M2 phenotype switch of macrophages. The figure was made with tools from www.proteinlounge.com
Fig. 2 The roles of macrophage in wound healing. In the early phase of wound repair, upon exposure to pro-inflammatory cytokines, interferons (IFNs), PAMPs or DAMPs, infiltrating monocytes and resident macrophages are activated and mainly acquire a pro-inflammatory M1 phenotype. They perform phagocytosis of microbes, scavenge cellular debris and produce pro-inflammatory mediators. Later during healing process, IL4, IL-10, Glucocorticoids, Prostaglandins (PGs) and modulators of glucose and lipid metabolism induce macrophages to transit to a reparative M2 phenotype, which secret anti-inflammatory mediators and growth factors. Macrophages also remove neutrophils in the wounds by phagocytosis, a central element to induce the M1-M2 phenotype switch of macrophages. The figure was made with tools from www.proteinlounge.comCC BY · PubMed Central

Verification

Claims the paper makes

81 Valid · 2 Not valid · 75 Not checked · 28 Own results and interpretations

101 more claims · 38 with their cited sources checked

Create a free account to see all 186 claims and to verify the 5 references still open.

See all claims — free account
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 69

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 275 references

Cited by

See all 1,980

Metadata

Authors
Landén, N. X., Li, D., & Ståhle, M.
Affiliations
Karolinska University Hospital (SE)
Venue
Cellular and Molecular Life Sciences
Published
2016-05-14
Volume
73
Issue
20
Pages
3861-3885
ISSN
  • 1420-682X (ISSN-L)
  • 1420-9071
OpenAlex
W2353982544
Cited by
1,980
References
275
Citations by year
2026: 276 · 2025: 360 · 2024: 328 · 2023: 234 · 2022: 237 · 2021: 188 · 2020: 161 · 2019: 97 · 2018: 69 · 2017: 24 · 2016: 5
FWCI
8.28
Type
journal article
Language
en
Open access
Locations
  • Cellular and Molecular Life Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Vetenskapsrådet (K2014-85X-22500-01-3)
  • Ragnar Söderbergs stiftelse
  • Hedlunds Foundation
  • Welander and Finsens Foundation
  • Åke Wibergs Foundation
  • Jeanssons Stiftelser
Topics
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
Keywords
wound healing, delayed wound healing, skin barrier repair, scar formation, therapeutic target, cellular and molecular mechanisms
MeSH terms
Animals, Disease Models, Animal, Humans, Inflammation, Models, Biological, Skin, Wound Healing, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transition from inflammation to proliferation: a critical step during wound healing. https://app.cochat.ai/papers/10.1007/s00018-016-2268-0
The paper
Landén, N. X., Li, D., & Ståhle, M. (2016). Transition from inflammation to proliferation: a critical step during wound healing. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-016-2268-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.